J. Kropff

Learn More
AIMS To assess the accuracy and reliability of the two most widely used continuous glucose monitoring (CGM) systems. METHODS We studied the Dexcom®G4 Platinum (DG4P; Dexcom, San Diego, CA, USA) and Medtronic Paradigm Veo Enlite system (ENL; Medtronic, Northridge, CA, USA) CGM systems, in 24 patients with type 1 diabetes. The CGM systems were tested during(More)
AIM To assess the impact on fear of hypoglycaemia and treatment satisfaction with an artificial pancreas system used for 2 consecutive months, as well as participant acceptance of the artificial pancreas system. METHODS In a randomized crossover trial patient-related outcomes associated with an evening-and-night artificial pancreas and sensor-augmented(More)
  • 1